Topical BioMedics earns patent for product used to treat fibromyalgia pain

RHINEBECK, N.Y. Topical BioMedics on Thursday announced that its Topricin pain relief and healing cream has been awarded a patent as a treatment of pain associated with fibromyalgia. A Food and Drug Administration-regulated topical biomedicine, Topricin was introduced by the company in 1994, the company stated.

More than 5 million people suffer from fibromyalgia, with the vast majority of them being women. The condition is characterized by chronic, widespread pain in muscles, ligaments and tendons; multiple “tender points”; fatigue; and sleep disturbances. Other symptoms include numbness and tingling, irritable bowel syndrome, palpitations and tension or migraine headaches. The soft-tissue pain of fibromyalgia is described as deep-aching, radiating, gnawing, shooting or burning, and ranges from mild to severe.

Topricin delivers a combination of homeopathic medicines to relieve pain. “Topricin has been effective in resolving pain for the many women suffering with fibromyalgia, with many reporting they have more energy [and] are staying more active, and [reporting] that [Topricin] has helped to reduce or eliminate their dependency on oral pain medications,” stated Lou Paradise, Topical BioMedics CEO.

Login or Register to post a comment.